Massachusetts' life sciences and startup ecosystem is facing a funding pullback, with venture capital share and the number of funded companies both declining in 2026.
After slowing in late 2025, layoffs hit Massachusetts life sciences companies again in early 2026, with 745 jobs cut across 14 firms in the first quarter.